BF*F allotype of the alternative pathway of complement: A marker of protection against the development of antiphospholipid antibodies in patients with systemic lupus erythematosus
Restricted accessResearch articleFirst published online April, 2016
BF*F allotype of the alternative pathway of complement: A marker of protection against the development of antiphospholipid antibodies in patients with systemic lupus erythematosus
B factor (BF) from the alternative complement pathway seems to participate in the pathophysiology of systemic lupus erythematosus (SLE) and antiphospholipid syndrome (APS).
Objective
To study the allotypic variability of BF in SLE and their associations with clinical and autoantibodies profile.
Methods
BF allotypes were determined by high-voltage agarose gel electrophoresis, under constant cooling, followed by immunofixation with anti-human BF antibody, in 188 SLE patients and 103 controls. Clinical and serological data were obtained from medical examination and records.
Results
No significant differences of BF variants between patients and controls were found, neither in relation to epidemiologic or clinical manifestations. Associations of phenotype BF SS07 and allotype BF*S07 were found with anticardiolipin IgM (aCl-IgM) antibodies (p = 0.014 and p = 0.009 respectively), but not with aCl-IgG, lupus anticoagulant (LA), anti β2GPI or clinical APS. A significant decrease in BF*F allotype (p = 0.043) and BF SF phenotype (p = 0.018) was detected in patients with anti-phospholipid antibodies as a whole (aCl-IgG, aCl-IgM, LA and anti β2GPI).
Conclusions
There is a link between phenotype BF SS07 and allotype BF*S07 with aCl-IgM in SLE patients; BF*F allotype could be considered a marker of protection against the development of antiphospholipid antibodies in these patients.
OrenRLauferJGoldbergI. C3, C4, factor B and HLA-DR alpha mRNA expression in renal biopsy specimens from patients with IgA nephropathy. Immunology1995; 86: 575–583.
SatoNOhsawaINagamachiS. Significance of glomerular activation of the alternative pathway and lectin pathway in lupus nephritis. Lupus2011; 20: 1378–1386.
7.
PrazFRuuthE. Growth-supporting activity of fragment Ba of the human alternative complement pathway for activated murine B lymphocytes. J Exp Med1986; 163: 1349–1354.
8.
PetersMGAmbrusJLJrFauciAS. The Bb fragment of complement factor B acts as a B cell growth factor. J Exp Med1988; 168: 1225–1235.
9.
HallREBlaeseRMDavisAE3rd. Cooperative interaction of factor B and other complement components with mononuclear cells in the antibody-independent lysis of xenogeneic erythrocytes. J Exp Med1982; 156: 834–843.
10.
LeijhPCvan den BarselaarMTDahaM. Stimulation of the intracellular killing of Staphylococcus aureus by monocytes: regulation by immunoglobulin G and complement components C3/C3b and B/Bb. J Immunol1982; 129: 332–337.
11.
GötzeOBiancoCCohnZA. The induction of macrophage spreading by factor B of the properdin system. J Exp Med1979; 149: 372–386.
12.
CzopJNussenzweigV. Studies on the mechanism of solubilization of immune precipitates by serum. J Exp Med1976; 143: 615–630.
13.
ManziSRairieJECarpenterAB. Sensitivity and specificity of plasma and urine complement split products as indicators of lupus disease activity. Arthritis Rheum1996; 39: 1178–1188.
14.
WatanabeHNoguchiEShioK. Usefulness of complement split product, Bb, as a clinical marker for disease activity of lupus nephritis. Fukushima J Med Sci2006; 52: 103–109.
15.
AlexanderJJJacobAVezinaP. Absence of functional alternative complement pathway alleviates lupus cerebritis. Eur J Immunol2007; 37: 1691–1701.
16.
WatanabeHGarnierGCircoloA. Modulation of renal disease in MRL/lpr mice genetically deficient in the alternative complement pathway factor B. J Immunol2000; 164: 786–794.
17.
da Rosa UtiyamaSRda Silva KotzeLMde Messias ReasonIT. Complement factor B allotypes in the susceptibility and severity of coeliac disease in patients and relatives. Int J Immunogenet2005; 32: 307–314.
18.
MessiasITReisAAlmeidaPT. Genetic variability of the MHC class III complement proteins C2, BF, C4A and C4B in southern Brazil. Exp Clin Immunogenet1994; 11: 192–196.
19.
Messias-ReasonIJUrbanetzLPereira da CunhaC. Complement C3 F and BF S allotypes are risk factors for Chagas disease cardiomyopathy. Tissue Antigens2003; 62: 308–312.
20.
HochbergMC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum1997; 40: 1725–1725.
21.
MiyakisSLockshinMDAtsumiT. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost2006; 4: 295–306.
22.
AlperCABoenichTWatsonL. Genetic polymorphism in human glycine-rich-beta-glicoprotein. J Exp Med1972; 135: 68–80.
23.
GeserickGAbbalMMauffGSiemensI. Factor B (BF) nomenclature statement. Complement Inflamm1990; 7: 255–260.
24.
Ramos-CasalsMCampoamorMTChamorroA. Hypocomplementemia in systemic lupus erythematosus and primary antiphospholipid syndrome: prevalence and clinical significance in 667 patients. Lupus2004; 13: 777–783.
25.
De CarolisSBottaASantucciS. Complementemia and obstetric outcome in pregnancy with antiphospholipid syndrome. Lupus2012; 21: 776–778.
26.
SarmientoEDaleJArrayaM. CD8+DR+ T-Cells and C3 complement serum concentration as potential biomarkers in thrombotic antiphospholipid syndrome. Autoimmune Dis2014; 2014: 868652–868652.
Carrera-MarínARomay-PenabadZPapalardoE. C6 knock-out mice are protected from thrombophilia mediated by antiphospholipid antibodies. Lupus2012; 21: 1497–1505.
29.
OberkerschRAttorresiAICalabreseGC. Low-molecular-weight heparin inhibition in classical complement activation pathway during pregnancy. Thromb Res2010; 125: e240–e245.
30.
CohenDBuurmaAGoemaereNN. Classical complement activation as a footprint for murine and human antiphospholipid antibody-induced fetal loss. J Pathol2011; 225: 502–511.
31.
LynchAMGibbsRSMurphyJR. Complement activation fragment Bb in early pregnancy and spontaneous preterm birth. Am J Obstet Gynecol2008; 199: 354.e1–8.
32.
National Center for Biotechnology Information. Online mendelian inheritance in man: An online catalogue of human genes and genetic disorders. http://www.ncbi.nlm.nih.gov/omim/. Entry 138470 (accessed 7 June 2015).
33.
lbertERittnerCGrosse-WildeHRecombination frequency and linkage disequilibrium between HL-A and Bf. In: Kissmeyer-NielsenF (ed). Histocompatibility Testing, Copenhagen: Munksgaard, 1975, pp. 941–944.
34.
Domenico SebastianiGMinisolaGGaleazziM. HLA class II alleles and genetic predisposition to the antiphospholipid syndrome. Autoimmun Rev2003; 2: 387–394.
35.
GoldsteinRMouldsJMSmithCD. MHC studies of the primary antiphospholipid antibody syndrome and of antiphospholipid antibodies in systemic lupus erythematosus. J Rheumatol1996; 23: 1173–1179.
